554 related articles for article (PubMed ID: 21376678)
21. Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets.
Mirandola L; Figueroa JA; Phan TT; Grizzi F; Kim M; Rahman RL; Jenkins MR; Cobos E; Jumper C; Alalawi R; Chiriva-Internati M
Oncotarget; 2015 Feb; 6(5):2812-26. PubMed ID: 25739119
[TBL] [Abstract][Full Text] [Related]
22. Inducible expression of cancer-testis antigens in human prostate cancer.
Heninger E; Krueger TE; Thiede SM; Sperger JM; Byers BL; Kircher MR; Kosoff D; Yang B; Jarrard DF; McNeel DG; Lang JM
Oncotarget; 2016 Dec; 7(51):84359-84374. PubMed ID: 27769045
[TBL] [Abstract][Full Text] [Related]
23. Cancer/testis-associated genes: identification, expression profile, and putative function.
Zendman AJ; Ruiter DJ; Van Muijen GN
J Cell Physiol; 2003 Mar; 194(3):272-88. PubMed ID: 12548548
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.
Yang P; Meng M; Zhou Q
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188558. PubMed ID: 33933558
[TBL] [Abstract][Full Text] [Related]
25. The potential value of cancer-testis antigens in ovarian cancer: Prognostic markers and targets for immunotherapy.
Lin L; Zou X; Nong W; Ge Y; Li F; Luo B; Zhang Q; Xie X
Immun Inflamm Dis; 2024 Jun; 12(6):e1284. PubMed ID: 38896069
[TBL] [Abstract][Full Text] [Related]
26. Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy.
Hambach L; Ling KW; Pool J; Aghai Z; Blokland E; Tanke HJ; Bruijn JA; Halfwerk H; van Boven H; Wieles B; Goulmy E
Blood; 2009 Mar; 113(12):2715-22. PubMed ID: 19096014
[TBL] [Abstract][Full Text] [Related]
27. Treatment of chronic lymphocytic leukemia with a hypomethylating agent induces expression of NXF2, an immunogenic cancer testis antigen.
Dubovsky JA; McNeel DG; Powers JJ; Gordon J; Sotomayor EM; Pinilla-Ibarz JA
Clin Cancer Res; 2009 May; 15(10):3406-15. PubMed ID: 19401350
[TBL] [Abstract][Full Text] [Related]
28. The potential immune-eliciting cancer testis antigens in colorectal cancer.
Chi Soh JE; Abu N; Jamal R
Immunotherapy; 2018 Sep; 10(12):1093-1104. PubMed ID: 30185136
[TBL] [Abstract][Full Text] [Related]
29. Coordinated expression of clustered cancer/testis genes encoded in a large inverted repeat DNA structure.
Bredenbeck A; Hollstein VM; Trefzer U; Sterry W; Walden P; Losch FO
Gene; 2008 May; 415(1-2):68-73. PubMed ID: 18395366
[TBL] [Abstract][Full Text] [Related]
30. Involvement of X-chromosome Reactivation in Augmenting Cancer Testis Antigens Expression: A Hypothesis.
Liu C; Luo B; Xie XX; Liao XS; Fu J; Ge YY; Li XS; Guo GS; Shen N; Xiao SW; Zhang QM
Curr Med Sci; 2018 Feb; 38(1):19-25. PubMed ID: 30074147
[TBL] [Abstract][Full Text] [Related]
31. Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.
Gjerstorff MF; Burns J; Ditzel HJ
Expert Opin Biol Ther; 2010 Jul; 10(7):1061-75. PubMed ID: 20420535
[TBL] [Abstract][Full Text] [Related]
32. Cancer testis antigens: a novel target in lung cancer.
Chiriva-Internati M; Pandey A; Saba R; Kim M; Saadeh C; Lukman T; Chiaramonte R; Jenkins M; Cobos E; Jumper C; Alalawi R
Int Rev Immunol; 2012 Oct; 31(5):321-43. PubMed ID: 23083344
[TBL] [Abstract][Full Text] [Related]
33. Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancers.
Yao J; Caballero OL; Yung WK; Weinstein JN; Riggins GJ; Strausberg RL; Zhao Q
Cancer Immunol Res; 2014 Apr; 2(4):371-9. PubMed ID: 24764584
[TBL] [Abstract][Full Text] [Related]
34. [Reseach Advances on Cancer-Testis Antigens in Multiple Myeloma -Review].
Yang ZR; Yu L; Zhu HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):296-300. PubMed ID: 28245420
[TBL] [Abstract][Full Text] [Related]
35. Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer.
Nin DS; Deng LW
Cells; 2023 Mar; 12(6):. PubMed ID: 36980267
[TBL] [Abstract][Full Text] [Related]
36. 5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications.
Coral S; Sigalotti L; Altomonte M; Engelsberg A; Colizzi F; Cattarossi I; Maraskovsky E; Jager E; Seliger B; Maio M
Clin Cancer Res; 2002 Aug; 8(8):2690-5. PubMed ID: 12171902
[TBL] [Abstract][Full Text] [Related]
37. Melanoma: a prototype of cancer-testis antigen-expressing malignancies.
Faramarzi S; Ghafouri-Fard S
Immunotherapy; 2017 Oct; 9(13):1103-1113. PubMed ID: 29032737
[TBL] [Abstract][Full Text] [Related]
38. Enhanced expression of cancer testis antigen genes in glioma stem cells.
Yawata T; Nakai E; Park KC; Chihara T; Kumazawa A; Toyonaga S; Masahira T; Nakabayashi H; Kaji T; Shimizu K
Mol Carcinog; 2010 Jun; 49(6):532-44. PubMed ID: 20082319
[TBL] [Abstract][Full Text] [Related]
39. Cancer/Testis genes in relation to sperm biology and function.
Babatunde KA; Najafi A; Salehipour P; Modarressi MH; Mobasheri MB
Iran J Basic Med Sci; 2017 Sep; 20(9):967-974. PubMed ID: 29085590
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: immunotherapeutic implications.
Coral S; Sigalotti L; Colizzi F; Spessotto A; Nardi G; Cortini E; Pezzani L; Fratta E; Fonsatti E; Di Giacomo AM; Nicotra MR; Natali PG; Altomonte M; Maio M
J Cell Physiol; 2006 Apr; 207(1):58-66. PubMed ID: 16252259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
